GUARDANT HEALTH, INC. Operating Cash Flow
GUARDANT HEALTH, INC. (GH) reported Operating Cash Flow of -$123.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-07-30
- GUARDANT HEALTH, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$57.78M.
- GUARDANT HEALTH, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$65.62M.
- GUARDANT HEALTH, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$26.37M.
- GUARDANT HEALTH, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$35.41M.
- GUARDANT HEALTH, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$184.76M.
- GUARDANT HEALTH, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$239.86M.
- GUARDANT HEALTH, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$324.98M.
- GUARDANT HEALTH, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$309.46M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$57.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$123.40M 10-Q · filed 2026-07-30 | -$149.77M derived: sum of 3 quarters · filed 2026-07-30 | -$185.19M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | -$65.62M 10-Q · filed 2026-05-07 | -$92.00M derived: sum of 2 quarters · filed 2026-05-07 | -$127.41M derived: sum of 3 quarters · filed 2026-05-07 | -$187.69M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | -$26.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$61.79M derived: sum of 2 quarters · filed 2026-02-19 | -$122.07M derived: sum of 3 quarters · filed 2026-07-30 | -$184.76M 10-K · filed 2026-02-19 |
| 2025-09-30 | -$35.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$95.70M derived: sum of 2 quarters · filed 2026-07-30 | -$158.39M 10-Q · filed 2025-10-29 | -$222.90M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | -$60.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$122.97M 10-Q · filed 2026-07-30 | -$187.49M derived: sum of 3 quarters · filed 2026-07-30 | -$238.55M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | -$62.69M 10-Q · filed 2026-05-07 | -$127.20M derived: sum of 2 quarters · filed 2026-05-07 | -$178.26M derived: sum of 3 quarters · filed 2026-05-07 | -$272.26M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$64.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$115.57M derived: sum of 2 quarters · filed 2026-02-19 | -$209.57M derived: sum of 3 quarters · filed 2026-02-19 | -$239.86M 10-K · filed 2026-02-19 |
| 2024-09-30 | -$51.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$145.06M derived: sum of 2 quarters · filed 2025-10-29 | -$175.34M 10-Q · filed 2025-10-29 | -$254.07M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | -$94.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | -$124.29M 10-Q · filed 2025-07-30 | -$203.01M derived: sum of 3 quarters · filed 2026-02-19 | -$280.81M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | -$30.28M 10-Q · filed 2025-04-30 | -$109.01M derived: sum of 2 quarters · filed 2026-02-19 | -$186.80M derived: sum of 3 quarters · filed 2026-02-19 | -$280.82M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | -$78.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$156.52M derived: sum of 2 quarters · filed 2026-02-19 | -$250.53M derived: sum of 3 quarters · filed 2026-02-19 | -$324.98M 10-K · filed 2026-02-19 |
| 2023-09-30 | -$77.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$171.81M derived: sum of 2 quarters · filed 2024-11-06 | -$246.25M 10-Q · filed 2024-11-06 | -$337.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | -$94.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$168.46M 10-Q · filed 2024-08-07 | -$259.20M derived: sum of 3 quarters · filed 2025-02-20 | -$337.37M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | -$74.44M 10-Q · filed 2024-05-09 | -$165.19M derived: sum of 2 quarters · filed 2025-02-20 | -$243.35M derived: sum of 3 quarters · filed 2025-02-20 | -$355.29M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | -$90.75M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | -$168.91M derived: sum of 2 quarters · filed 2025-02-20 | -$280.84M derived: sum of 3 quarters · filed 2025-02-20 | -$309.46M 10-K · filed 2025-02-20 |
| 2022-09-30 | -$78.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$190.09M derived: sum of 2 quarters · filed 2023-11-06 | -$218.71M 10-Q · filed 2023-11-06 | -$295.70M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | -$111.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$140.55M 10-Q · filed 2023-08-03 | -$217.54M derived: sum of 3 quarters · filed 2024-02-22 | -$270.69M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | -$28.62M 10-Q · filed 2023-05-09 | -$105.61M derived: sum of 2 quarters · filed 2024-02-22 | -$158.75M derived: sum of 3 quarters · filed 2024-02-22 | -$221.34M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | -$76.99M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$130.13M derived: sum of 2 quarters · filed 2024-02-22 | -$192.73M derived: sum of 3 quarters · filed 2024-02-22 | -$209.02M 10-K · filed 2024-02-22 |
| 2021-09-30 | -$53.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$115.74M derived: sum of 2 quarters · filed 2022-11-03 | -$132.03M 10-Q · filed 2022-11-03 | -$191.25M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | -$62.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$78.88M 10-Q · filed 2022-08-04 | -$138.11M derived: sum of 3 quarters · filed 2023-02-23 | -$146.16M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | -$16.29M 10-Q · filed 2022-05-05 | -$75.51M derived: sum of 2 quarters · filed 2023-02-23 | -$83.57M derived: sum of 3 quarters · filed 2023-02-23 | -$106.94M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | -$59.22M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$67.28M derived: sum of 2 quarters · filed 2023-02-23 | -$90.64M derived: sum of 3 quarters · filed 2023-02-23 | -$103.93M 10-K · filed 2023-02-23 |
| 2020-09-30 | -$8.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$31.42M derived: sum of 2 quarters · filed 2021-11-04 | -$44.70M 10-Q · filed 2021-11-04 | -$75.05M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | -$23.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$36.65M 10-Q · filed 2021-08-05 | -$66.99M derived: sum of 3 quarters · filed 2022-02-24 | -$65.64M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | -$13.28M 10-Q · filed 2021-05-06 | -$43.62M derived: sum of 2 quarters · filed 2022-02-24 | -$42.28M derived: sum of 3 quarters · filed 2022-02-24 | -$56.11M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | -$30.34M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$29.00M derived: sum of 2 quarters · filed 2022-02-24 | -$42.83M derived: sum of 3 quarters · filed 2022-02-24 | -$47.13M 10-K · filed 2022-02-24 |
| 2019-09-30 | $1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$12.49M derived: sum of 2 quarters · filed 2020-11-05 | -$16.79M 10-Q · filed 2020-11-05 | -$43.33M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$13.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$18.14M 10-Q · filed 2020-08-06 | -$44.68M derived: sum of 3 quarters · filed 2021-02-25 | -$66.72M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$4.30M 10-Q · filed 2020-05-07 | -$30.84M derived: sum of 2 quarters · filed 2021-02-25 | -$52.89M derived: sum of 3 quarters · filed 2021-02-25 | -$69.93M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$26.54M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$48.59M derived: sum of 2 quarters · filed 2021-02-25 | -$65.63M derived: sum of 3 quarters · filed 2021-02-25 | -$72.19M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$22.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$39.09M derived: sum of 2 quarters · filed 2019-11-07 | -$45.65M 10-Q · filed 2019-11-07 | -$63.64M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | -$17.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$23.60M 10-Q · filed 2019-08-07 | -$41.59M derived: sum of 3 quarters · filed 2020-03-02 | |
| 2018-03-31 | -$6.56M 10-Q · filed 2019-05-10 | -$24.55M derived: sum of 2 quarters · filed 2020-03-02 | ||
| 2017-12-31 | -$17.99M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$72.23M 10-K · filed 2020-03-02 | ||
| 2017-09-30 | -$54.25M 10-Q · filed 2018-11-19 | |||
| 2016-12-31 | -$36.71M 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |